STOCK TITAN

Israel Acq A (ISRLF) Financials

ISRLF OTC
Trailing 12 months to June 30, 2026
Revenue Not reported for the trailing 12 months
Net Income -$577K -143.2% YoY
EPS (Diluted) Not reported for the trailing 12 months
Operating Cash Flow -$167K -110.9% YoY
Market Cap $75.7M as of Nov 2, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ISRLF SEC filings page.

This page shows Israel Acq Corp A (ISRLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ISRLF FY2025

The asset base is contracting while liabilities remain larger than assets, leaving negative equity and weaker short-term coverage.

FY2024’s net income of $2.8M was accompanied by operating cash flow of $3.3M, so reported earnings had cash support. In FY2025, the company posted a net loss of $510K and operating cash flow of -$258K, showing that the reversal reached cash generation too.

Assets fell 87.9% from FY2024 to FY2025, while liabilities fell 79.9%; obligations therefore shrank more slowly than the asset base. By FY2025, liabilities were 180.1% of assets and equity was negative at -$8.0M, indicating that contraction did not restore balance-sheet solvency.

The current ratio dropped from 12.0x in FY2024 to 1.2x in FY2025, reducing the cushion available against near-term obligations. Current liabilities still rose 16.6% during that contraction, indicating that the remaining pressure is concentrated in short-term obligations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Israel Acq Corp A, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/6

Israel Acq Corp A passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$65K
YoYn/m
QoQn/m

Israel Acq Corp A reported a net loss of $65K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$2K
YoY-97.0%
QoQ-94.7%

Israel Acq Corp A held $2K in cash as of Q2 2026; no long-term debt figure is on record for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

Share Buybacks
$0
YoYn/m
QoQ-100.0%

Israel Acq Corp A repurchased no shares in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

ISRLF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Income-$127Kn/m-$245Kn/m-$253Kn/m-$281Kn/m-$349Kn/m-$281Kn/m-$250Kn/m-$234Kn/m
Net Income-$65Kn/m-$173K-359.4%-$158K-122.8%-$180K-122.2%-$238K-132.2%$67K-88.4%$695K$811K-54.2%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

ISRLF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$6.4M-33.7%$6.4M-32.8%$10.0M-87.9%$9.9M-87.9%$9.7M-88.0%$9.5M-88.1%$82.6M-46.5%$81.6M-46.6%
Current Assets$6.4M-33.7%$6.4M-32.8%$10.0M-87.9%$9.9M-87.9%$9.7M-88.0%$9.5M-88.1%$82.6M-46.5%$81.6M-46.6%
Cash & Equivalents$2K-97.0%$33K+19.8%$7K-67.4%$64K+138.9%$57K-14.4%$27K-91.5%$21K-96.8%$27K-96.7%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$14.8M-13.9%$14.6M-11.9%$18.0M-79.9%$17.8M-79.8%$17.2M-80.1%$16.6M-80.5%$89.5M-43.9%$88.0M-44.0%
Current Liabilities$8.4M+10.0%$8.3M+15.0%$8.0M+16.6%$8.0M+23.4%$7.6M+22.9%$7.2M+18.5%$6.9M+21.4%$6.5M+17.1%
Non-Current Liabilities$6.4M-33.0%$6.3M-32.5%$9.9M-88.0%$9.8M-88.0%$9.6M-88.1%$9.4M-88.1%$82.6M-46.3%$81.5M-46.3%
Total Equity-$8.4Mn/m-$8.2Mn/m-$8.0Mn/m-$7.9Mn/m-$7.5Mn/m-$7.1Mn/m-$6.9Mn/m-$6.5Mn/m
Retained Earnings-$8.4Mn/m-$8.3Mn/m-$8.1Mn/m-$7.9Mn/m-$7.5Mn/m-$7.1Mn/m-$6.9Mn/m-$6.5Mn/m

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

ISRLF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$20Kn/m-$82Kn/m$38K-95.6%-$103K-112.1%-$59K-107.5%-$134K-115.8%$865K+186.3%$855Kn/m
Investing Cash Flow-$71Kn/m$3.6M-$178Kn/m-$184Kn/m-$182Kn/mN/A-$1.1Mn/m-$1.2Mn/m
Financing Cash Flow$60K-77.8%-$3.5M$84K-62.8%$294K-2.1%$271K+80.6%N/A$225Kn/m$300Kn/m
Share Buybacks$0n/m$3.7M$0n/m$0n/m$0n/mN/A$0$0

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.

ISRLF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ISRLF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-1.0%+1.5pp-2.7%-3.4pp-1.6%-2.4pp-1.8%-2.8pp-2.5%-3.4pp0.7%0.0pp0.8%1.0%-0.2pp
Current Ratio0.76-0.5x0.77-0.5x1.24-10.8x1.23-11.3x1.27-11.7x1.32-11.8x12.01-15.3x12.53-14.9x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$8.0M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Israel Acq Corp A ISRLF FY2025 N/A -$510K N/A $75.7M —
Piermont Valley Acq A CMCAF FY2026 N/A -$1.7M N/A $77.4M —
Intl Media Acq Corp A IMAQ FY2026 N/A -$345K N/A $71.8M —
Chain Bridge I A CBRRF FY2025 N/A -$1.3M N/A $63.9M —
theglobe.com inc TGLO FY2025 $0 -$226K N/A $58.2M —
Spark I Acq Corp A SPKLF FY2025 N/A $294K N/A $102.1M —

Frequently Asked Questions

No, Israel Acq Corp A (ISRLF) reported a net loss of $577K over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $510K.

Israel Acq Corp A (ISRLF) recorded an outflow of $258K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Israel Acq Corp A (ISRLF) had $10.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Israel Acq Corp A (ISRLF) had 1M shares outstanding as of fiscal year 2025.

Israel Acq Corp A (ISRLF) had a current ratio of 1.24 as of fiscal year 2025, which is considered adequate.

Israel Acq Corp A (ISRLF) had a return on assets of -5.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Israel Acq Corp A (ISRLF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $75.7M as of Nov 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Israel Acq Corp A (ISRLF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $75.7M as of Nov 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Israel Acq Corp A (ISRLF) has negative shareholder equity of -$8.0M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Israel Acq Corp A (ISRLF) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top